COL18A1 and chronic obstructive pulmonary disease: For instance, in chronic obstructive pulmonary disease, plasma endostatin was significantly increased in patients with, and strongly associated with disease severity, decreased lung function, increased systemic inflammation and increased number of exacerbations [20,21].